Edition:
United States

Theravance Biopharma Inc (TBPH.OQ)

TBPH.OQ on NASDAQ Stock Exchange Global Market

27.65USD
4:00pm EDT
Change (% chg)

$0.81 (+3.02%)
Prev Close
$26.84
Open
$26.98
Day's High
$28.16
Day's Low
$26.90
Volume
50,733
Avg. Vol
72,936
52-wk High
$35.83
52-wk Low
$21.27

Chart for

About

Theravance Biopharma, Inc. is a biopharmaceutical company. The Company is engaged in creating medicines for patients suffering from serious illness. The Company operates in the segment of discovery (research), development and commercialization of human therapeutics. The Company's pipeline of internally discovered product... (more)

Overall

Beta: 1.89
Market Cap(Mil.): $1,514.81
Shares Outstanding(Mil.): 55.10
Dividend: --
Yield (%): --

Financials

  TBPH.OQ Industry Sector
P/E (TTM): -- 28.12 30.20
EPS (TTM): -4.89 -- --
ROI: -63.76 13.07 12.77
ROE: -188.52 15.04 14.92

BRIEF-Theravance Expects To Report Data From Phase 2A Study In nOH Patients By July End

* THERAVANCE BIOPHARMA TO HOST KEY OPINION LEADER EVENT FOCUSED ON THE UNMET MEDICAL NEED IN THE TREATMENT OF NEUROGENIC ORTHOSTATIC HYPOTENSION

May 17 2018

BRIEF-Theravance Biopharma Q4 Revenue $4.5 Million

* THERAVANCE BIOPHARMA, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Feb 27 2018

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $68.85 +1.48
The Medicines Company (MDCO.OQ) $39.53 -0.25
GlaxoSmithKline plc (GSK.L) 1,610.00 +19.60
AstraZeneca plc (AZN.L) 5,936.00 -6.00
Novartis AG (NOVN.S) CHF81.72 +0.86

Earnings vs. Estimates